Sequana Medical developed Alfapump® for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders.
The alfapump® is a fully-implanted, programmable, wireless, CE-marked system that automatically pumps ascites from the peritoneal cavity into the bladder, where the body eliminates the ascites naturally through urination.
Multiple clinical studies show a significant reduction in the need for large volume paracentesis, where at least 5 litres of fluid is removed (i.e., the current standard of care), and a significant improvement in patients’ quality of life.
The alfapump® treats ascites at home without the risk of hepatic encephalopathy and is associated with improved quality of life.
The use of the alfapump® may potentially improve clinical outcomes through enabling both greater anti-cancer treatment intensity and therapeutic monitoring via liquid biopsies.
The alfapump® delivers a safe and effective long-term alternative and dramatically reduces the need for repeated invasive procedures.
The alfapump® addresses the clear unmet patient needs in liver refractory ascites and malignant ascites, delivering a clinically effective and convenient therapy that improves patient quality of life.